Relation between infusion rate of indomethacin and cerebral blood flow velocity

Pediatrics International

Volumn 52, Issue 4, 2010, Pages 616-621

  Kondo, Masatoshi ^a,b   Kunikata, Tetsuya ^a   Okazaki, Kaoru ^a   Yasuda, Saneyuki ^c   Isobe, Kenichi ^c   Itoh, Susumu ^c  

^a EHIME PREFECTURAL CENTRAL HOSPITAL   (Japan)

^b Tokyo Metropolitan Hachioji Children's Hospital   (Japan)

^c KAGAWA UNIVERSITY   (Japan)

Author keywords

cerebral blood flow velocity; indomethacin; patent ductus arteriosus; pharmacokinetics

Indexed keywords

DOBUTAMINE; DOPAMINE; INDOMETACIN;

ARTICLE; BLOOD FLOW VELOCITY; BRAIN BLOOD FLOW; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG ELIMINATION; DRUG HALF LIFE; DRUG INFUSION; DRUG SAFETY; DUCTUS ARTERIOSUS OBLITERATION; FEMALE; HUMAN; INFUSION RATE; MALE; NEWBORN; NEWBORN INTENSIVE CARE; PATENT DUCTUS ARTERIOSUS; PRIORITY JOURNAL; PROSPECTIVE STUDY;

BLOOD FLOW VELOCITY; CEREBROVASCULAR CIRCULATION; DUCTUS ARTERIOSUS, PATENT; FEMALE; HUMANS; INDOMETHACIN; INFANT, NEWBORN; INFUSIONS, INTRAVENOUS; MALE; ULTRASONOGRAPHY, DOPPLER;

EID: 77955809125     PISSN: 13288067     EISSN: 1442200X     Source Type: Journal    
DOI: 10.1111/j.1442-200X.2010.03126.x     Document Type: Article

References (24)

1. Bancalari E. Changes in the pathogenesis and prevention of chronic lung disease of prematurity. Am. J. Perinatol. 2001 18 : 1 9.
2. Chung MY, Fang PC, Chung CH, Huang CB, Ou Yang MH, Chen CC. Risk factors for hemodynamically-unrelated cystic periventricular leukomalacia in very low birth weight premature infants. J. Formos. Med. Assoc. 2005 104 : 571 7.
3. Friedman WF, Hirschklau MJ, Printz MP, Pitlick PT, Kirkpatrick SE. Pharmacologic closure of patent ductus arteriosus in the premature infant. N. Engl. J. Med. 1976 295 : 526 9.
4. Heymann MA, Rudolph AM, Silverman NH. Closure of the ductus arteriosus in premature infants by inhibition of prostaglandin synthesis. N. Engl. J. Med. 1976 295 : 530 33.
5. Kumar RK, Yu VYH. Prolonged low-dose indomethacin therapy for patent ductus arteriosus in very low birthweight infants. J. Paediatr. Child Health 1997 33 : 38 41.
6. Bhat R, Fisher E, Raju TNK, Vidyasagar D. Patent ductus arteriosus: Recent advances in diagnosis and management. Pediatr. Clin. North Am. 1982 29 : 1117 36.
7. Edwards AD, Wyatt JS, Richardson C et al. Effects of indomethacin on cerebral haemodynamics in very preterm infants. Lancet 1990 335 : 1491 95.
8. Van Bel F, Van de Bor M, Stijnen T, Baan J, Ruys JH. Cerebral blood flow velocity changes in preterm infants after a single dose of indomethacin: Duration of its effect. Pediatrics 1989 84 : 802 7.
9. Benders MJNL, Dorrepaal CA, Van de Bor M, Van Bel F. Acute effects of indomethacin on cerebral hemodynamics and oxygenation. Biol. Neonate 1995 68 : 91 9.
10. Mosca F, Bray M, Lattanzio M, Fumagalli M, Tosetto C. Comparative evaluation of the effects of indomethacin and ibuprofen on cerebral perfusion and oxygenation in preterm infants with patent ductus arteriosus. J. Pediatr. 1997 131 : 549 54.
11. 133xenon clearance. J. Pediatr. 1984 104 : 411 18.
12. Rosenberg AA, Narayanan V, Jones MD Jr. Comparison of anterior cerebral artery blood flow velocity and cerebral blood flow during hypoxia. Pediatr. Res. 1985 19 : 67 70.
13. Sonesson SE, Herin P. Intracranial arterial blood flow velocity and brain blood flow during hypocarbia and hypercarbia in newborn lambs: A validation of range-gated Doppler ultrasound flow velocimetry. Pediatr. Res. 1988 24 : 423 6.
14. Yasuda S, Itoh S, Okubo K et al. A basic investigation of the plasma indomethacin measurement. Jpn. J. Dev. Pharmacol. Ther. 2003 16 : 83 6.
15. Mawatari K, Iinuma F, Watanabe M. Fluorimetric determination of indomethacin in human serum by high-performance liquid chromatography coupled with post-column photochemical reaction with hydrogen peroxide. J. Chromatogr. 1989 491 : 389 96.
16. Coceani F, White E, Bodach E, Olley PM. Age-dependent changes in the response of the lamb ductus arteriosus to oxygen and ibuprofen. Can. J. Physiol. Pharmacol. 1979 57 : 825 31.
17. Patel J, Marks KA, Roberts I, Azzopardi D, Edwerd AD. Ibuprofen treatment of patent ductus arteriosus. Lancet 1995 346 : 255.
18. Hammerman C, Glaser J, Schimmel MS, Ferber B, Kaplan M, Eidelman AI. Continuous versus multiple rapid infusion of indomethacin: Effect on cerebral blood flow velocity. Pediatrics 1995 95 : 244 8.
19. Simko A, Mardoum R, Merritt TA, Bejar R. Effects on cerebral blood flow velocities of slow and rapid infusion of indomethacin. J. Periantol. 1994 14 : 29 35.
20. Molinari F, Liboni W, Grippi G, Negri E. Relationship between oxygen supply and cerebral blood flow assessed by transcranial Doppler and near-infrared spectroscopy in healthy subjects during breath-holding. J. Neuroeng. Rehabil. 2006 19 : 16 28.
21. Talji AA, Carr I, Yeh TF, Raval D, Luken JA, Pildes RS. Pharmacokinetics of intravenously administered indomethacin in preterm infants. J. Pediatr. 1980 97 : 995 1000.
22. Yeh TF, Achanti B, Patel H, Pildes RS. Indomethacin therapy in preterm infants with patent ductus arteriosus: Determination of therapeutic plasma levels. Dev. Pharmacol. Ther. 1989 12 : 169 78.
23. Yaffe SJ, Friedman WF, Rogers D, Lang P, Ragni M, Saccar C. The disposition of indomethacin in preterm babies. J. Pediatr. 1980 97 : 1001 6.
24. Evans MA, Bhat R, Vidyasagar D, Vadapalli M, Fisher E, Hastreiter A. Gestational age and indomethacin elimination in the neonate. Clin. Pharmacol. Ther. 1979 26 : 746 51.